Advances in surgical treatment of intrahepatic cholangiocarcinoma

doi:10.16139/j.1007-9610.2022.02.003

Abstract

CLC Number:

R735.7

LIU Shenyang, TANG Zhaohui, QUAN Zhiwei. Advances in surgical treatment of intrahepatic cholangiocarcinoma[J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 100-106.

References 48

[1]	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3):209-249. doi: 10.3322/caac.21660 URL
[2]	童焕军, 于小鹏, 汤朝晖. 从病因学角度看肝内胆管癌的异质性[J]. 肝胆胰外科杂志, 2021, 33(11):641-646.
[3]	Hwang S, Lee YJ, Song GW, et al. Prognostic impact of tumor growth type on 7th AJCC staging system for intrahepatic cholangiocarcinoma: a single-center experience of 659 cases[J]. J Gastrointest Surg, 2015, 19(7):1291-1304. doi: 10.1007/s11605-015-2803-6 pmid: 25820487
[4]	Wu L, Tsilimigras DI, Paredes AZ, et al. Trends in the incidence, treatment and outcomes of patients with intrahepatic cholangiocarcinoma in the USA: facility type is associated with margin status, use of lymphadenectomy and overall survival[J]. World J Surg, 2019, 43(7):1777-1787. doi: 10.1007/s00268-019-04966-4 URL
[5]	Valle JW, Kelley RK, Nervi B, et al. Biliary tract cancer[J]. Lancet, 2021, 397(10272):428-444. doi: 10.1016/S0140-6736(21)00153-7 pmid: 33516341
[6]	Moris D, Tsilimigras DI, Kostakis LD, et al. Anatomic versus non-anatomic resection for hepatocellular carcinoma: a systematic review and meta-analysis[J]. EJSO, 2018, 44(7):927-938. doi: 10.1016/j.ejso.2018.04.018 URL
[7]	Moris D, Ronnekleiv-Kelly S, Rahnemai-Azar AA, et al. Parenchymal-sparing versus anatomic liver resection for colorectal liver metastases: a systematic review[J]. J Gastrointest Surg, 2017, 21(6):1076-1085. doi: 10.1007/s11605-017-3397-y URL
[8]	Si A, Li J, Yang Z, et al. Impact of anatomical versus non-anatomical liver resection on short- and long-term outcomes for patients with intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol, 2019, 26(6):1841-1850. doi: 10.1245/s10434-019-07260-8 URL
[9]	Zhang XF, Bagante F, Chakedis J, et al. Perioperative and long-term outcome for intrahepatic cholangiocarcinoma: impact of major versus minor hepatectomy[J]. J Gastrointest Surg, 2017, 21(11):1841-1850. doi: 10.1007/s11605-017-3499-6 URL
[10]	Li MX, Bi XY, Li ZY, et al. Impaction of surgical margin status on the survival outcome after surgical resection of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis[J]. J Surg Res, 2016, 203(1):163-173. doi: 10.1016/j.jss.2016.02.012 URL
[11]	Zhu H, Wang L, Wang M, et al. Prognostic value of resection margin length after surgical resection for intrahepatic cholangiocarcinoma[J]. Am J Surg, 2021, 222(2):383-389. doi: 10.1016/j.amjsurg.2020.12.022 URL
[12]	Murakami S, Ajiki T, Okazaki T, et al. Factors affecting survival after resection of intrahepatic cholangiocarcinoma[J]. Surg Today, 2014, 44(10):1847-1854. doi: 10.1007/s00595-013-0825-9 pmid: 24452507
[13]	van Vugt JLA, Gaspersz MP, Coelen RJS, et al. The prognostic value of portal vein and hepatic artery involvement in patients with perihilar cholangiocarcinoma[J]. HPB(Oxford), 2018, 20(1):83-92.
[14]	Reames B, Pawlik TM, Ejaz A, et al. Impact of major vascular resection on short- and long-term outcomes in patients with intrahepatic cholangiocarcinoma[J]. J Clin Oncol, 2017, 35(4_suppl):275.
[15]	Reames BN, Ejaz A, Koerkamp BG, et al. Impact of major vascular resection on outcomes and survival in patients with intrahepatic cholangiocarcinoma: a multi-institutional analysis[J]. J Surg Oncol, 2017, 116(2):133-139. doi: 10.1002/jso.24633 URL
[16]	Navarro JG, Lee JH, Kang I, et al. Prognostic significance of and risk prediction model for lymph node metastasis in resectable intrahepatic cholangiocarcinoma: do all require lymph node dissection?[J]. HPB(Oxford), 2020, 22(10):1411-1419.
[17]	Chang ME, Lei HJ, Chen MH, et al. Evaluation of prognostic factors and implication of lymph node dissection in intrahepatic cholangiocarcinoma: 10-year experience at a tertiary referral center[J]. J Chin Med Assoc, 2017, 80(3):140-146. doi: 10.1016/j.jcma.2016.09.010 URL
[18]	Kim DH, Choi DW, Choi SH, et al. Is there a role for systematic hepatic pedicle lymphadenectomy in intrahe-patic cholangiocarcinoma? a review of 17 years of expe-rience in a tertiary institution[J]. Surgery, 2015, 157(4):666-675. doi: 10.1016/j.surg.2014.11.006 URL
[19]	Zhou R, Lu D, Li W, et al. Is lymph node dissection ne-cessary for resectable intrahepatic cholangiocarcinoma? a systematic review and meta-analysis[J]. HPB(Oxford), 2019, 21(7):784-792.
[20]	Yoh T, Cauchy F, Le Roy B, et al. Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: a multicenter study[J]. Surgery, 2019, 166(6):975-982. doi: 10.1016/j.surg.2019.06.025 URL
[21]	Kim SH, Han DH, Choi GH, et al. Oncologic impact of lymph node dissection for intrahepatic cholangiocarcinoma: a propensity score-matched study[J]. J Gastrointest Surg, 2019, 23(3):538-544. doi: 10.1007/s11605-018-3899-2 URL
[22]	Tamandl D, Kaczirek K, Gruenberger B, et al. Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma[J]. Br J Surg, 2009, 96(8):919-925. doi: 10.1002/bjs.6654 pmid: 19591163
[23]	Sweigert PJ, Eguia E, Janjua H, et al. Does resection improve overall survival for intrahepatic cholangiocarcinoma with nodal metastases?[J]. Surg Open Science, 2020, 2(3):107-112. doi: 10.1016/j.sopen.2020.04.003 URL
[24]	Guglielmi A, Ruzzenente A, Campagnaro T, et al. Patterns and prognostic significance of lymph node dissection for surgical treatment of perihilar and intrahepatic cholangiocarcinoma[J]. J Gastrointest Surg, 2013, 17(11):1917-1928. doi: 10.1007/s11605-013-2331-1 pmid: 24048613
[25]	Benson AB 3rd, D'Angelica MI, Abbott DE, et al. NCCN guidelines insights: hepatobiliary cancers, version 1.2017[J]. J Natl Compr Canc Netw, 2017, 15(5):563-573. doi: 10.6004/jnccn.2017.0059 URL
[26]	Okami J, Dono K, Sakon M, et al. Patterns of regional lymph node involvement in intrahepatic cholanglocarcinoma of the left lobe[J]. J Gastrointeat Surg, 2003, 7(7):850-856.
[27]	Barth MJ. NCCN clinical practice guidelines in oncology (NCCN Guidelines)[J]. J Natl Compr Canc Netw, 2020, 18(11):1105. doi: 10.6004/jnccn.2020.0036 URL
[28]	Zhang XF, Xue F, Dong DH, et al. Number and station of lymph node metastasis after curative-intent resection of intrahepatic cholangiocarcinoma impact prognosis[J]. Ann Surg, 2021, 274(6):E1187-E1195.
[29]	Xiong Y, Jingdong L, Zhaohui T, et al. A consensus meeting on expert recommendations on operating specifications for laparoscopic radical resection of hilar cholangiocarcinoma[J]. Front Surg, 2021, 8:731448.
[30]	Weber SM, Jarnagin WR, Klimstra D, et al. Intrahepatic cholangiocarcinoma: Resectability, recurrence pattern, and outcomes[J]. J Am Coll Surg, 2001, 193(4):384-391. doi: 10.1016/S1072-7515(01)01016-X URL
[31]	Franken LC, Coelen RJS, Roos E, et al. Staging Laparoscopy in patients with intrahepatic cholangiocarcinoma: is it still useful?[J]. Visceral Medicine, 2020, 36(6):501-505. doi: 10.1159/000506297 pmid: 33442552
[32]	Swaid F, Sucandy I, Tohme S, et al. Changes in performance of more than 1000 minimally invasive liver resections[J]. JAMA Surg, 2020, 155(10):986-988. doi: 10.1001/jamasurg.2020.2623 URL
[33]	Ciria R, Cherqui D, Geller DA, et al. Comparative short-term benefits of laparoscopic liver resection: 9000 cases and climbing[J]. Ann Surg, 2016, 263(4):761-777. doi: 10.1097/SLA.0000000000001413 URL
[34]	Wu J, Han J, Zhang Y, et al. Safety and feasibility of laparoscopic versus open liver resection with associated lymphadenectomy for intrahepatic cholangiocarcinoma[J]. Biosci Trends, 2020, 14(5):376-383. doi: 10.5582/bst.2020.03293 URL
[35]	Haber PK, Wabitsch S, Kaestner A, et al. Laparoscopic liver resection for intrahepatic cholangiocarcinoma: a single-center experience[J]. J Laparoendosc Adv Surg Tech A, 2020, 30(12):1354-1359. doi: 10.1089/lap.2020.0215 URL
[36]	Shiraiwa DK, Carvalho PFDC, Maeda CT, et al. The role of minimally invasive hepatectomy for hilar and intrahe-patic cholangiocarcinoma: a systematic review of the lite-rature[J]. J Surg Oncol, 2020, 121(5):863-872. doi: 10.1002/jso.25821 pmid: 31902142
[37]	Wei F, Wang G, Din J, et al. Is it time to consider laparoscopic hepatectomy for intrahepatic cholangiocarcinoma? a meta-analysis[J]. J Gastrointest Surg, 2020, 24(10):2244-2250. doi: 10.1007/s11605-019-04404-9 URL
[38]	Ziogas IA, Giannis D, Esagian SM, et al. Laparoscopic versus robotic major hepatectomy: a systematic review and meta-analysis[J]. Surg Endosc, 2021, 35(2):524-535. doi: 10.1007/s00464-020-08008-2 URL
[39]	Qiu J, Chen S, Du C. A systematic review of robotic-assisted liver resection and meta-analysis of robotic versus laparoscopic hepatectomy for hepatic neoplasms[J]. Surg Endosc, 2016, 30(3):862-875. doi: 10.1007/s00464-015-4306-7 URL
[40]	Di Benedetto F, Magistri P. First case of full robotic ALPPS for intrahepatic cholangiocarcinoma[J]. Ann Surg Oncol, 2021, 28(2):865.
[41]	Hong K, Georgiades C. Radiofrequency ablation: mechanism of action and devices[J]. J Vasc Interv Radiol, 2010, 21(8):S179-S186.
[42]	Andreano A, Brace CL. A comparison of direct heating during radiofrequency and microwave ablation in ex vivo liver[J]. Cardiovasc Intervent Radiol, 2013, 36(2):505-511. doi: 10.1007/s00270-012-0405-1 pmid: 22572764
[43]	Rubinsky B, Lee CY, Bastacky J, et al. The process of freezing and the mechanism of damage during hepatic cryosurgery[J]. Cryobiology, 1990, 27(1):85-97. pmid: 2311412
[44]	Savic LJ, Chapiro J, Hamm B, et al. Irreversible electroporation in interventional oncology: where we stand and where we go[J]. Rofo, 2016, 188(8):735-745. doi: 10.1055/s-0042-104203 pmid: 27074423
[45]	Kim GH, Kim PH, Kim JH, et al. Thermal ablation in the treatment of intrahepatic cholangiocarcinoma: a systema-tic review and meta-analysis[J]. Eur Radiol, 2021, 32(2):1205-1215. doi: 10.1007/s00330-021-08216-x URL
[46]	Chu HH, Kim JH, Shin YM, et al. Percutaneous radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection: multivariable analysis of factors predicting survival outcomes[J]. Am J Roentgenol, 2021, 217(2):426-432. doi: 10.2214/AJR.20.23461 URL
[47]	Sapisochin G, Rodriguez de Lope C, Gastaca M, et al. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation[J]. Ann Surg, 2014, 259(5):944-952. doi: 10.1097/SLA.0000000000000494 pmid: 24441817
[48]	Sapisochin G, Rodríguez de Lope C, Gastaca M, et al. “Very early” intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients?[J]. Am J Transplant, 2014, 14(3):660-667. doi: 10.1111/ajt.12591 pmid: 24410861

Advances in surgical treatment of intrahepatic cholangiocarcinoma

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 48

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	YE Feng, GONG Xiaoyong, REN Jiajun, CAI Qiang, CHEN Sheng. Application of ERCP in diagnosis and treatment of biliary complications during perioperative period of primary liver cancer [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 355-360.
[2]	CHANG Jessica, CHEN Xuxiao, CHEN Yongjun. Role of the spleen in patients with liver cancer and cirrhosis [J]. Journal of Surgery Concepts & Practice, 2023, 28(04): 394-398.
[3]	ZHANG Hui, GONG Ling, GUO Qian, LUO Yan. Retrospective study on sugammadex for reversal of neuromuscular blockade after radiofrequency ablation of hepatic carcinoma under general anesthesia [J]. Journal of Surgery Concepts & Practice, 2023, 28(01): 72-76.
[4]	ZHANG Jixiang, XIE Zhihua, LI Wei, JIANG Xiaoqing. Classification of intrahepatic cholangiocarcinoma and hot topics in surgical treatment [J]. Journal of Surgery Concepts & Practice, 2022, 27(05): 478-482.
[5]	YIN Yanjiang, LUO Zhiwen, CHEN Xiao, ZHANG Yefan, HUANG Zhen, ZHAO Hong, ZHAO Jianjun, LI Zhiyu, ZHOU Jianguo, CAI Jianqiang, BI Xinyu. Relationship between surgical margin and prognosis of patients with intrahepatic cholangiocarcinoma [J]. Journal of Surgery Concepts & Practice, 2022, 27(03): 221-228.
[6]	CHEN Congyan, WANG Junqing, CHEN Yongjun. Gut microbiota and mechanism of liver cancer [J]. Journal of Surgery Concepts & Practice, 2022, 27(03): 256-260.
[7]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 93-94.
[8]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 95-99.
[9]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 107-112.
[10]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 113-118.
[11]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 119-122.
[12]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 123-127.
[13]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 128-130.
[14]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 131-133.
[15]	. [J]. Journal of Surgery Concepts & Practice, 2022, 27(02): 134-138.